Pfizer Inc (PFE) — Technical state
As of 2026-09-24 — re-computed nightly across the coverage universe. Closelooknet diary readings, not advice.
Trades +5.8% vs the 50-day and +8.3% vs the 200-day average, 2.7% below the 52-week high and +24.7% off the 52-week low; a golden cross printed 11 sessions ago. Computed from daily closes.
The moving-average stack
- vs 20-day+1.4%
- vs 50-day+5.8%
- vs 200-day+8.3%
- 52-week band2.7% off the high · +24.7% off the low
- Streak6 consecutive up sessions
- CrossoverGolden cross 11 sessions ago
- 50-day crossprice crossed up through the 50-day 37 sessions ago
- Stochastic%K 72.5 · %D 35.7
Continue: the PFE chart & overview · the signal board
FAQ · from the current data · as of 2026-09-24
Quick answers
What is the current Closelooknet signal on PFE?
Uptrend stack intact — Trades +5.8% vs the 50-day and +8.3% vs the 200-day average, 2.7% below the 52-week high and +24.7% off the 52-week low; a golden cross printed 11 sessions ago. Computed from daily closes. As of 2026-09-24; the signal board re-computes across the coverage universe nightly. A research diary reading, not advice.
Is PFE above its 50-day and 200-day moving averages?
As of 2026-09-24, Pfizer Inc trades +5.8% above its 50-day and +8.3% above its 200-day average, with the 20-day +1.4% away.
How far is PFE from its 52-week high?
2.7% below the 52-week high and 24.7% above the 52-week low, as of 2026-09-24.
Mentioned on Closelooknet
Where PFE appears in the diary — 7 pieces, newest first. Every link is our own writing.
Go deeper
Dailies
- Rubin surges as vol complex splits and Europe extends gains
- Layer-1 chips surge as Europe and US futures fade
The reading sits just above the neutral midpoint, consistent with a market that has bounced but not yet committed to a sustained risk-on regime. §11 — Pattern Scanner Active 28 signals · PFE 36 🟡 support-confluence · MCD 36 🟡…
- Narrow tape: Rubin leads as broad market softens across asset classes
The Pattern Scanner shows 28 active signals, all support-confluence, with defensive names (PFE, MCD, NOC, LMT, HD) testing support in red regimes.
- Vol complex splits as bond stress offsets equity calm
Four of five carry a 🔴 regime label (NOC, MCD, UL, LMT); only PFE (🟡, 47% confidence) prints caution rather than outright stress.
- Friday flips broadly risk-off — Korea −6.1%, Temperature still 57
Pattern Scanner: 25 active signals, top-5 all support-confluence — PFE 47 (🟡), NOC 38 (🔴), MCD 37 (🔴), AZN 36 (🟡), UL 29 (🔴) — three red, two yellow, zero green.
- Temperature 59 — Rubin surges 25% monthly as cointegration breaks pile up
The top five hits are all support-confluence reads — NOC, MCD, PFE, JNJ, and MA — with the two highest-confidence names, NOC and MCD, carrying red-regime labels.
- Temperature 59 — first crack in semis, defensives bid
The Pattern Scanner registered 28 active signals, top five clustered in support-confluence setups: NOC at 41 confidence and MCD at 37, both in red regimes, alongside PFE and JNJ in yellow.
Related in the Closelooknet universe
then Drug Manufacturers - General, then Healthcare. Scored names rank on their Closelooknet score; names without one rank on trend state — above or below their 50- and 200-day averages — never on a score they do not carry.
- LLY Eli Lilly and Companyindustry
- SAN.PA Sanofi SAindustry
- NVO Novo Nordisk A/Sindustry
- AMGN Amgen Incindustry
- GSK GlaxoSmithKline PLC ADRindustry
- GRF.MC Grifols S.A.industry
- BIIB Biogen Incindustry
- GILD Gilead Sciences Incindustry
- MRK Merck & Company Incindustry
- ORNBV.HE Orion Oyj Bindustry
- ORNAV.HE Orion Oyj Aindustry
- ABBV AbbVie Incindustry
- JNJ Johnson & Johnsonindustry
- OGN Organon & Coindustry
- BMY Bristol-Myers Squibb Companyindustry
- SNY Sanofi ADRindustry
- AZN AstraZeneca PLCindustry
- HALO Halozyme Therapeutics Incsector
- DXCM DexCom Incsector
- ARGX argenx NV ADRsector